FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is using inecalcitol for treating and/or preventing rachitis, osteoporosis, osteomalatia, psoriasis, autoimmune diseases, such as multiple sclerosis, type I diabetes mellitus, hyperparathyroid, benign prostate hyperplasia, any kinds of cancer in doses containing from 1.5 mg/day to 4 mg at intervals specified in: every second day, once a day or twice a day.
EFFECT: treating the patients suffering hormone resistant prostate cancer with inecalcitol, which implies no inadmissible toxicity or disease progression has been shown.
10 cl, 4 dwg
